Références
Cette liste rassemble la base de preuves externe du livre : la littérature citable et évaluée par les pairs qui sous-tend les affirmations cliniques. Le texte principal du livre est rédigé dans un langage accessible au patient et ne remplace pas ces sources – c'est ici que le lecteur intéressé (et le médecin traitant) en trouvera le fondement.
Références
[7] van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013. Link
Short summary of the cited reference is in preparation.
[36] Cammarota G, Ianiro G, Tilg H et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017. Link
Short summary of the cited reference is in preparation.
[45] Kao D, Roach B, Silva M et al. Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA. 2017. Link
Short summary of the cited reference is in preparation.
[59] Thaiss CA, Zeevi D, Levy M et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014. Link
Short summary of the cited reference is in preparation.
[159] Chassaing B, Koren O, Goodrich JK et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015. Link
Short summary of the cited reference is in preparation.
[160] Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017. Link
Short summary of the cited reference is in preparation.
[204] Allen JM, Mailing LJ, Niemiro GM et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018. Link
Short summary of the cited reference is in preparation.
[207] Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015. Link
Short summary of the cited reference is in preparation.
[218] Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011. Link
Short summary of the cited reference is in preparation.
[339] Suez J, Zmora N, Zilberman-Schapira G et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell. 2018. Link
Short summary of the cited reference is in preparation.
[346] Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015. Link
Short summary of the cited reference is in preparation.
[347] Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, McDonald LC; Emerging Infections Program Clostridioides difficile Infection Working Group. Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. N Engl J Med. 2020. Link
Short summary of the cited reference is in preparation.
[349] Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, Wilcox MH. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021. Link
Short summary of the cited reference is in preparation.
[357] Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997. Link
Short summary of the cited reference is in preparation.
[365] Reed AD, Theriot CM. Contribution of Inhibitory Metabolites and Competition for Nutrients to Colonization Resistance against Clostridioides difficile by Commensal Clostridium. Microorganisms. 2021. Link
Short summary of the cited reference is in preparation.
[369] Weingarden A, González A, Vázquez-Baeza Y, Weiss S, Humphry G, Berg-Lyons D, Knights D, Unno T, Bobr A, Kang J, Khoruts A, Knight R, Sadowsky MJ. Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome. 2015. Link
Short summary of the cited reference is in preparation.
[637] Sonnenburg ED, Smits SA, Tikhonov M et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016. Link
Short summary of the cited reference is in preparation.
[2721] Palleja A, Mikkelsen KH, Forslund SK et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology. 2018. Link
Short summary of the cited reference is in preparation.
[2722] Grosen AK et al. Effects of clinical donor characteristics on the success of faecal microbiota transplantation for patients in Denmark with Clostridioides difficile infection: a single-centre, prospective cohort study. The Lancet Microbe. 2025. Link
Short summary of the cited reference is in preparation.
Remarque : les éléments ci-dessus constituent la base de preuves externe et citable du livre. Les documents sources internes de MicroBiome Bank (DiffBiome / HospBiome Service Datasheet, SIS Clinical Guide, guide de protocole clinique v2.1, protocole de densité des capsules, fiches DSQ, stratégie d'élimination de C. diff 2026) fournissent les faits spécifiques au produit et au protocole ; il ne s'agit pas d'éléments de littérature publique, mais des propres documents référencés du prestataire.